Disclosures for "Pregnancy Outcomes Following Exposure to Lacosamide: Prospective Data from Spontaneous and Solicited Reports"
-
The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Epilepsy Foundation. The institution of Dr. Perucca has received research support from Royal Australasian College of Physicians. The institution of Dr. Perucca has received research support from Melbourne Health. The institution of Dr. Perucca has received research support from Monash University. The institution of Dr. Perucca has received research support from Epilepsy Foundation . The institution of Dr. Perucca has received research support from Victorian Medical Research Acceleration Fund. The institution of Dr. Perucca has received research support from Sanming Project Grant, Shenzhen government. The institution of Dr. Perucca has received research support from Brain Australia. The institution of Dr. Perucca has received research support from Medical Research Future Fund. The institution of Dr. Perucca has received research support from Weary Dunlop Medical Research Foundation. The institution of Dr. Perucca has received research support from Norman Beischer Medical Research Foundation. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Austin Medical Research Foundation.
-
Dr. Bourikas has nothing to disclose.
-
The institution of Dr. Voinescu has received research support from NIH. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Neurodiem. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Physicians' Education Resouce. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Epilepsy Society. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with Epilepsy Ireland that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
-
The institution of Dr. Vadlamudi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Vadlamudi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
-
Daya Chellun has nothing to disclose.
-
Thomas Kumke has nothing to disclose.
-
Konrad Werhahn has received personal compensation for serving as an employee of UCB Pharma. Konrad Werhahn has stock in UCB Pharma.
-